AQST

Aquestive Therapeutics, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-04

Figures on this page computed 2026-11-08 12:48 UTC

Last close

3.66USD

Market data, 2026-11-05

Except where said otherwise: 10-K for 2025, filed 2026-03-04

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001398733-26-000018
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-04
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001398733-26-000018
Reported in
USD
- 10-K for 2025, filed 2026-03-04
- 10-K for 2025, filed 2026-03-04
- 10-K for 2025, filed 2026-03-04
- 10-Q for 2025, filed 2026-11-03
- 10-K for 2025, filed 2026-03-04
- 10-Q for 2025, filed 2026-11-03
The filing itself
-188.1%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001398733-26-000018
Reported in
USD
- 10-K for 2025, filed 2026-03-04
- 10-K for 2025, filed 2026-03-04
The filing itself
-119.0%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001398733-26-000018
Reported in
USD
- 10-K for 2025, filed 2026-03-04
- 10-K for 2025, filed 2026-03-04
The filing itself
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001398733-26-000018
Reported in
USD
- 10-K for 2025, filed 2026-03-04
- 10-Q for 2025, filed 2026-11-03
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Growth is the furthest below its sector's middle: 0.16 against 0.50 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Six questions

lens 5 of 9

Six questions

0 yes of 4 answered

1Does it earn money?no
net margin, read above 0.
2Can it pay what it owes?Not known
interest coverage, read above 3. We do not hold that figure for this company.
3Is it bigger than five years ago?no
rev growth 5y, read above 0.
4Does the profit turn into cash?no
fcf margin, read above 0.
5Is it issuing shares?no
share count change yoy, read below 1.
6Is it priced under twenty times earnings?Not known
pe ratio, read below 20. We do not hold that figure for this company.

2 of these could not be answered. That is not a no: it is a figure we do not hold, and it is left as what it is.

0 of 4 questions answered yes; 2 could not be answered.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-03-04

Does it earn money?-188.1%
Source
filed
Statement
income
Fiscal year
2025
Accession
0001398733-26-000018
Reported in
USD
The filing itself
Can it pay what it owes?n/a
Not held.
Source
filed
Statement
income
Fiscal year
2025
Accession
0001398733-26-000018
Reported in
USD
The filing itself
Is it bigger than five years ago?-0.6%
Source
filed
Statement
income
Fiscal year
2025
Accession
0001398733-26-000018
Reported in
USD
The filing itself
Does the profit turn into cash?-119.0%
Source
filed
Statement
income
Fiscal year
2025
Accession
0001398733-26-000018
Reported in
USD
The filing itself
Is it issuing shares?23.3%
Source
filed
Statement
income
Fiscal year
2025
Accession
0001398733-26-000018
Reported in
USD
The filing itself
Is it priced under twenty times earnings?n/a
Not held.
Source
filed
Statement
income
Fiscal year
2025
Accession
0001398733-26-000018
Reported in
USD
The filing itself